Skip to content

MiniMed Fit Payload Wear Pediatric Study

CIP361: MiniMed Fit Payload Wear Pediatric Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07675161
Enrollment
59
Registered
2026-06-30
Start date
2026-06-25
Completion date
2026-08-07
Last updated
2026-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes (DM), Diabetes in Adolescence, Diabetes in Children, Diabetes (Insulin-requiring, Type 1 or Type 2)

Brief summary

The purpose of this study is to assess MiniMed Fit Payload adhesive components in different wear locations over a 7-day period to support development of the future commercialized patch pump in participants 7-17 years of age.

Interventions

The MiniMed Fit Payload device used in this study will be made of polycarbonate materials, will not contain any electronic or mechanical components, and is intended to mimic the shape and weight of a future product. Each device will consist of the payload assembly and an adhesive patch, which will be adhered to the payload on one side and the subject's skin on the other.

Sponsors

Medtronic MiniMed, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
7 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Participants with insulin-requiring diabetes * Participants 7-17 years of age * Participant and parent/guardian/legally authorized representative are able and willing to sign informed consent/assent

Exclusion criteria

* Participants who report known skin sensitivity or allergy to polycarbonate or pressure-sensitive adhesives, e.g., medical device adhesives, band-aids, other acrylic-containing adhesives. * Participants with any skin condition in the area where device placement (e.g., irritation, rash, infection) could occur, per participant report. * Participants who are pregnant (per self-report) at initial screening. If a participant becomes pregnant during the study, the site will follow procedures for study withdrawal.

Design outcomes

Primary

MeasureTime frameDescription
Summary of device survival7 DaysThe number of MiniMed Fit Payload that remain securely attached to the skin at the end of day 7. This is a descriptive endpoint.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 26, 2026